The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) are recommended as first-line drugs for hypertension with diabetic nephropathy owing to their renoprotective effect; however, their effect beyond lowering blood pressure (BP) has not been confirmed. Recent stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuda, Yasuyuki, Ito, Sadayoshi, Kashihara, Naoki, Shikata, Kenichi, Nangaku, Masaomi, Wada, Takashi, Sawanobori, Tomoko, Taguri, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899688/
https://www.ncbi.nlm.nih.gov/pubmed/36100672
http://dx.doi.org/10.1038/s41440-022-01008-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899688/
https://www.ncbi.nlm.nih.gov/pubmed/36100672
http://dx.doi.org/10.1038/s41440-022-01008-w

Ejemplares similares